# Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK

> **NCT00216034** · PHASE3 · COMPLETED · sponsor: **Hokuriku-Kinki Immunochemotherapy Study Group** · enrollment: 255 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Tegafur-gimeracil-oteracil potassium (TS-1)
- **DRUG:** Krestin (PSK)

## Key facts

- **NCT ID:** NCT00216034
- **Lead sponsor:** Hokuriku-Kinki Immunochemotherapy Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2016-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00216034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00216034, "Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00216034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*